Loading
Latest filing published 18 Sept 2026 for Knight Therapeutics Inc., €960. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Arvind Utchanah discloses dealings in Knight Therapeutics Inc. to SEDI. In total, 6 filings cover trades dated from 15 June 2026 to 15 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 18 September 2026, reports a share grant of €960 in Knight Therapeutics Inc. Filings reach the SEDI feed a median of 3 days after the trade. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations